This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. According to an August 2019 federal report , past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Public health and safety programs. Key Findings. General funds.
Use of the term ‘cannabis’ instead of ‘marijuana’ does not influence the public’s perception of the plant or their attitudes, according to data published in the journal PLOS One. ” Full text of the study, “Has the ‘M’ word been framed?
As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform. A number of U.S.
In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. The FDA also highlighted the issue it has proclaimed since May 2019, when the CBD Policy Working Group held a public hearing–“many unanswered questions and data gaps about CBD toxicity” remain.
Winter Edition 2019 – Cannabis. 2019 Legislative Session – Agency Proposed Legislation. Leaf Data Systems Update. On January 9, 2019 the Board approved a motion to make the effective date for all marijuana product, packaging and labeling requirements Jan 1, 2020. Here’s the Table of Contents.
But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. First responders in Denver, Colorado, will soon have another tool to support their community: psychedelic harm reduction.
This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.
January 31, 2019. Portland, OR — Today the Oregon Liquor Control Commission provided the Oregon Legislative Assembly with the 2019 Recreational Marijuana Supply and Demand Legislative Report required by ORS 475B.548. 2019 Recreational Marijuana Supply and Demand Legislative Report. Here’s the statement in full.
These results raise safety and efficacy concerns. According to new research by Grand View Research (2019), the global CBD market is forecasted to reach US$ 9.69 According to Orian Research Group (2019), CBD products could account for about 0.15% of the global health and wellness market value by 2028. TEL AVIV, Israel , Feb.
In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.
Crash rates spiked with the legalization of recreational marijuana use and retail sales in California, Colorado, Nevada, Oregon and Washington, a new study by the Insurance Institute for Highway Safety (IIHS) and another by the affiliated Highway Loss Data Institute (HLDI) show. Insurance Institute for Highway Safety.
As an industry, our primary concern is the safety and well-being of our consumers. Although investigations and data collection are ongoing, it appears that most, if not all, of the reported cannabis-related cases so far stem from products sourced from the unregulated criminal market.
Friday, May 31st, 2019. . at the Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019. If you are interested in submitting comments after the hearing, comments must be posted to the public docket before July 2, 2019.
The Legal Aid Society, an organization offering pro bono legal assistance to New York City’s most marginalized communities, is calling attention to new NYPD data showing that 94 percent of all cannabis arrests in 2020 targeted people of color. View original article.
“FDA continually asked the companies for meetings and safetydata about their products containing full-spectrum hemp extract. After complying with FDA’s requests, these companies saw FDA reject their NDI notifications—disregarding published peer-reviewed toxicology studies and years’ worth of real-world safety evidence.
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.
It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. 600 USD raised of $400 goal.
“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.
Colorado marijuana dispensaries passed underage sales checks at a 95 percent rate in 2021, according to the MED, slightly down from 97 percent in 2020 and 2019. ” The MED conducted 604 underage compliance checks at dispensaries in 2019, according to department data, but that number dropped to 118 in 2020 and 80 in 2021.
While RSO has been subject to increased popularity in treating certain types of cancers, no clinical trials have tested the safety or efficacy of RSO in humans, meaning that all evidence is anecdotal. So until now, we have been missing an important area of research, which is real world data of people using cannabinoids.
Data from the Denver District Attorney’s office shows only 47 cases related to psychedelic mushrooms since May 2019 decriminalization. The panel that includes District Attorney Beth McCann, law enforcement officers and psilocybin advocate Kevin Matthews was formed after 2019, when Denver voters were the first in the U.S.
According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.
CBD for Pets Yes the Data says it works ! Lets review some data. Since then, numerous studies have provided lots of clinical data that CBD can help manage a wide variety of tremors, spasms, and tics. Several months ago, there was a thunder and lightning storm and my dog, Jing, went under the bed for safety as fast as she could….She
In the 2019 and 2020 fiscal years, state officials reported that revenue from the 37% cannabis retail tax outpaced alcohol tax revenue, despite the fact that many more adults consume alcohol than cannabis. The city of Denver, for example, applies an additional 5.5% local sales tax on adult-use cannabis and has collected $210.6 46,104,922.
In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?
Google announced in May, 2019 that they had updated their policy section of the Google to ban apps “that facilitate the sale of marijuana or maijruan products, regardless of legality.” As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”.
Since its passing in 2016, Prop 64 has earmarked its entire cannabis industry tax revenue, minus regulatory costs, to supporting public health, repairing the environment, and bettering public safety. Marijuana Tax Revenue Expenditures in California (Fiscal Year 2019-2020). 20 percent to public safety initiatives.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.
The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.
This data is particularly important for drivers, would-be drivers, policy makers, and anyone who is involved in carrying out or supervising safety sensitive tasks. Determining intoxication and impairment with cannabis is notoriously difficult and is nearly impossible to peg it to a per se limit of THC or its metabolites in the blood.
On Friday, January 10, 2019, the California Bureau of Cannabis Control (BCC) issued an email press release entitled, “Consolidation of California Cannabis Licensing Authorities” concerning a budget proposal released by Governor Gavin Newsom. The budget estimates that about $332.8
In May 2019, Denver became the first city in the United States to decriminalize personal possession, cultivation and storage of psilocybin mushrooms. The initiative also created the Denver Psilocybin Policy Review Panel (“Panel”), which was required to report back to the City on the public safety and other impacts of decriminalization.
Based on the details of a June 21 press release, the trials—which are taking place in Johannesburg—are the first ethically approved studies exploring the suitability and safety of using cannabis as a substitute for opioid pain relievers. . According to the 2019 National Survey on Drug Use and Health , an estimated 10.1
However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Shutterstock). What’s in your CBD?
FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under state law. FDA submitted this report last week, as is discussed below.
The FDA is reopening the public docket established in May 2019 for the submission of data related to the efficacy and safety of Cannabidiol. The docket includes a mechanism for stakeholders to submit data and information that is confidential. Read More › Tags:
The survey found that from 2009-2019 there were “no change” in the rate of cannabis consumption among high school students. Using the same data analyzed under a quadratic change model, lifetime cannabis consumption showed a clear decrease during that same time period. According to the recent CDC report, 21.7%
For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. ” The study is titled Dosage, efficacy, and safety of cannabidiol administration in adults: A systematic review of human trials.
In his statement, Commissioner Hahn noted that the FDA was working on: 1) continuing to educate the public on the risks of CBD; 2) seeking reliable data on the safety and benefits of CBD, including opening the public docket on the matter; and 3) monitoring the marketplace for the sale and marketing of unapproved drugs.
WORCESTER—Today the Cannabis Control Commission (Commission) announced adult-use Marijuana Establishments in Massachusetts surpassed $3 billion in gross sales , according to the information that licensees report in the state’s mandatory seed-to-sale tracking system and is publicly available through the Commission’s Open Data Platform.
These results raise safety and efficacy concerns. According to new research by Grand View Research (2019), the global CBD market is forecasted to reach US$ 9.69 According to Orian Research Group (2019), CBD products could account for about 0.15% of the global health and wellness market value by 2028. TEL AVIV, Israel , Feb.
In 2019, a small study tested CBD ointment for its therapeutic potential within the skin, including patients with acne, dermatitis, and psoriasis. The results were very positive and showed the safety and effectiveness of the topical CBD.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content